External Validation of Robust Radiomic Signature to Predict 2-Year Overall Survival in Non-Small-Cell Lung Cancer.

Lung cancer is the second most fatal disease worldwide. In the last few years, radiomics is being explored to develop prediction models for various clinical endpoints in lung cancer. However, the robustness of radiomic features is under question and has been identified as one of the roadblocks in th...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Digital Imaging Vol. 36; no. 6; pp. 2519 - 2532
Autores principales: Jha, Ashish Kumar, Sherkhane, Umeshkumar B., Mthun, Sneha, Jaiswar, Vinay, Purandare, Nilendu, Prabhash, Kumar, Wee, Leonard, Rangarajan, Venkatesh, Dekker, Andre
Formato: research tables/charts Journal Article
Publicado: Springer Nature Dec2023
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=173050927&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 173050927
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        08971889
        DOQ
      jtl: Journal of Digital Imaging
      issn: 08971889
      maglogo: N
    pubinfo:
      dt: Dec2023
      vid: 36
      iid: 6
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        173050927
        172268802
        173050927
        173050927
        10.1007/s10278-023-00835-8
        173050927
      ppf: 2519
      ppct: 13
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: External Validation of Robust Radiomic Signature to Predict 2-Year Overall Survival in Non-Small-Cell Lung Cancer.
      aug:
        au:
          Jha, Ashish Kumar
          Sherkhane, Umeshkumar B.
          Mthun, Sneha
          Jaiswar, Vinay
          Purandare, Nilendu
          Prabhash, Kumar
          Wee, Leonard
          Rangarajan, Venkatesh
          Dekker, Andre
        affil: https://ror.org/02jz4aj89 Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands
      sug:
        subj:
          External Validity
          Carcinoma, Non-Small-Cell Lung
          Human
          Overall Survival
          Retrospective Design
          Prospective Studies
          Chi Square Test
          Internal Validity
          Prediction Models
      ab: Lung cancer is the second most fatal disease worldwide. In the last few years, radiomics is being explored to develop prediction models for various clinical endpoints in lung cancer. However, the robustness of radiomic features is under question and has been identified as one of the roadblocks in the implementation of a radiomic-based prediction model in the clinic. Many past studies have suggested identifying the robust radiomic feature to develop a prediction model. In our earlier study, we identified robust radiomic features for prediction model development. The objective of this study was to develop and validate the robust radiomic signatures for predicting 2-year overall survival in non-small cell lung cancer (NSCLC). This retrospective study included a cohort of 300 stage I–IV NSCLC patients. Institutional 200 patients' data were included for training and internal validation and 100 patients' data from The Cancer Image Archive (TCIA) open-source image repository for external validation. Radiomic features were extracted from the CT images of both cohorts. The feature selection was performed using hierarchical clustering, a Chi-squared test, and recursive feature elimination (RFE). In total, six prediction models were developed using random forest (RF-Model-O, RF-Model-B), gradient boosting (GB-Model-O, GB-Model-B), and support vector(SV-Model-O, SV-Model-B) classifiers to predict 2-year overall survival (OS) on original data as well as balanced data. Model validation was performed using 10-fold cross-validation, internal validation, and external validation. Using a multistep feature selection method, the overall top 10 features were chosen. On internal validation, the two random forest models (RF-Model-O, RF-Model-B) displayed the highest accuracy; their scores on the original and balanced datasets were 0.81 and 0.77 respectively. During external validation, both the random forest models' accuracy was 0.68. In our study, robust radiomic features showed promising predictive performance to predict 2-year overall survival in NSCLC.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N